Clinical Study

A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Assignment Study To Assess The Efficacy And Safety Of Reparixin In Pancreatic Islet Auto-Transplantation.

Posted Date: Aug 12, 2017

  • Investigator: Syed Ahmad
  • Co-Investigator: Kimberly Jacob Anderson
  • Specialties:
  • Type of Study: Drug

The main purpose of this study is to evaluate the safety and effectiveness of the study drug in patients who have undergone pancreatic islet auto-transplantation.


To Be Eligible Patients Must Have Been Diagnosed With Chronic Pancreatitis And Are Scheduled To Have Pancreas Removed And Have A Pancreatic Islet Auto-Transplant


Pancreatic Islet Auto-Transplantation, Chronic, Rep0112, Pancreatitis, Null

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Enhanced Recovery Program for Colorectal Surgery Patients Reduces Costs

    A standardized protocol for managing patients for the duration of colorectaloperations not only improved clinical outcomes, but also it significantlyreduced hospital costs.